Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi G A, Michelassi C
Dialysis and Nephrology Unit, S.M. Annunziata Hospital, Florence, Italy.
Kidney Int. 1996 Dec;50(6):2103-8. doi: 10.1038/ki.1996.535.
We carried out a cross sectional and longitudinal study to assess whether bioimpedance indexes (resistance, Rz; reactance, Xc; phase angle, PA) reflect the nutritional status of hemodialysis (HD) patients, and bear a significant association with their long-term survival. The bioimpedance data of 131 patients on chronic HD treatment were compared with those of 272 healthy controls matched for age and sex. Nutritional status was assessed by anthropometric variables, serum albumin (SA), normalized protein catabolic rate (nPCR), and subjective global assessment (SGA). All three bioimpedance indexes varied significantly with HD treatment, however, with the exception of Xc in post-HD, they were on average significantly (P < 0.016) different from controls either pre- and post-HD. Post-HD PA appeared to be the best index of nutritional status, being significantly correlated with SA, age, mid arm muscle circumference (MAMC), SGA, and nPCR (R2 = 0.44; P < 0.01). However, depending on the cut-off levels, PA failed to detect clinically overt malnutrition in one to two thirds of the patients with the worst SGA score. During the follow-up the changes in bioimpedance indexes reflected poorly the changes in dry blood weight, only delta Rz bore a significant correlation (r = 0.29; P < 0.01) with delta body wt. Patients having baseline phase angle values within the lower quartile had a significantly lower two-year survival rate than patients having higher values (59.3% vs. 91.3%; P < 0.01). Cox's analysis (proportional hazard model) showed that phase angle as a predictor of death outweighed all other parameters included in the model (age, SA, nPCR, MAMC, SGA), with a relative risk of 2.6 (95% CI = 1.6 to 4.2). Bioimpedance indexes do not appear to be reliable in detecting clinically overt depletion of lean body mass. However, the strong association of PA with patient survival suggests that this bioimpedance index reflects some dimension of the illness, which is not fully identifiable with the deranged nutritional status.
我们开展了一项横断面和纵向研究,以评估生物电阻抗指标(电阻,Rz;电抗,Xc;相位角,PA)是否能反映血液透析(HD)患者的营养状况,以及是否与患者的长期生存存在显著关联。将131例接受慢性HD治疗的患者的生物电阻抗数据与272例年龄和性别相匹配的健康对照者的数据进行比较。通过人体测量变量、血清白蛋白(SA)、标准化蛋白分解代谢率(nPCR)和主观全面评定法(SGA)评估营养状况。所有三项生物电阻抗指标在HD治疗过程中均有显著变化,然而,除HD后Xc外,HD前后它们与对照组相比平均均有显著差异(P < 0.016)。HD后PA似乎是营养状况的最佳指标,与SA、年龄、上臂中部肌肉周长(MAMC)、SGA和nPCR显著相关(R2 = 0.44;P < 0.01)。然而,根据截断水平,PA未能在三分之一至三分之二SGA评分最差的患者中检测出临床明显的营养不良。在随访期间,生物电阻抗指标的变化很难反映干体重的变化,只有ΔRz与Δ体重有显著相关性(r = 0.29;P < 0.01)。基线相位角值处于下四分位数的患者的两年生存率显著低于相位角值较高的患者(59.3%对91.3%;P < 0.01)。Cox分析(比例风险模型)显示,作为死亡预测指标的相位角比模型中纳入的所有其他参数(年龄、SA、nPCR、MAMC、SGA)更具权重,相对风险为2.6(95%CI = 1.6至4.2)。生物电阻抗指标在检测临床明显的瘦体重消耗方面似乎并不可靠。然而,PA与患者生存的强关联表明,该生物电阻抗指标反映了疾病的某些方面,而这些方面不能完全通过紊乱的营养状况来识别。